[1] |
Riega-Torres JC, Villarreal-Gonzalez AJ, Ceceñas-Falcon LÁ,et al. Sjögren′s syndrome (SS), a review of the subject and saliva as a diagnostic method[J]. Gac Med Mex, 2016, 152(3):371-380.
|
[2] |
|
[3] |
|
[4] |
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren′s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002, 61(6):554-558. DOI: 10.1136/ard.61.6.554.
|
[5] |
Nikitakis NG, Rivera H, Lariccia C, et al. Primary Sjögren syndrome in childhood: report of a case and review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2003, 96(1):42-47. DOI: 10.1016/s1079-2104(03)00159-8.
|
[6] |
Thouret MC, Sirvent N, Triolo V, et al. Primary Gougerot-Sjögren syndrome in a 13-year-old girl[J]. Arch Pediatr, 2002, 9(2):142-146. DOI: 10.1016/s0929-693x(01)00722-9.
|
[7] |
|
[8] |
Bogdanović R, Basta-Jovanović G, Putnik J, et al. Renal involvement in primary Sjogren syndrome of childhood: case report and literature review[J]. Mod Rheumatol, 2013, 23(1):182-189. DOI: 10.1007/s10165-012-0633-x.
|
[9] |
姚莉,张岩,李羽. 儿童原发性干燥综合征误诊为流行性腮腺炎1例[J]. 人民军医,2011, 54(3): 193.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
Psianou K, Panagoulias I, Papanastasiou AD, et al. Clinical and immunological parameters of Sjögren′s syndrome[J]. Autoimmun Rev, 2018, 17(10):1053-1064. DOI: 10.1016/j.autrev.2018.05.005.
|
[16] |
|
[17] |
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren′s syndrome: a consensus and data-driven methodology involving three international patient cohorts[J]. Arthritis Rheumatol, 2017, 69(1): 35-45. DOI: 10.1002/art.39859.
|
[18] |
Saraux A, Pers JO, Devauchelle-Pensec V. Treatment of primary Sjögren syndrome[J]. Nat Rev Rheumatol, 2016, 12(8):456-471. DOI: 10.1038/nrrheum.2016.100.
|
[19] |
Vivino FB, Carsons SE, Foulks G, et al. New treatment guidelines for Sjögren′s disease[J]. Rheum Dis Clin North Am, 2016, 42(3):531-551. DOI: 10.1016/j.rdc.2016.03.010.
|
[20] |
Ramos-Casals M, Brito-Zerón P, Bombardieri S, et al. EULAR recommendations for the management of Sjögren′s syndrome with topical and systemic therapies[J]. Ann Rheum Dis, 2020, 79(1):3-18. DOI: 10.1136/annrheumdis-2019-216114.
|
[21] |
Price EJ, Baer AN. How to treat Sjögren′s syndrome?[J]. Rheumatology (Oxford), 2019, key363. Online ahead of print. DOI: 10.1093/rheumatology/key363.
|
[22] |
Carsons SE, Vivino FB, Parke A, et al. Treatment guidelines for rheumatologic manifestations of Sjögren′s syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain[J]. Arthritis Care Res (Hoboken), 2017, 69(4):517-527. DOI: 10.1002/acr.22968.
|
[23] |
|
[24] |
|
[25] |
|